key: cord-0779280-jh0zywrq
authors: Korath, Anna D. J.; Janda, Jozef; Untersmayr, Eva; Sokolowska, Milena; Feleszko, Wojciech; Agache, Ioana; Adel Seida, Ahmed; Hartmann, Katrin; Jensen‐Jarolim, Erika; Pali‐Schöll, Isabella
title: One Health: EAACI Position Paper on coronaviruses at the human‐animal interface, with a specific focus on comparative and zoonotic aspects of SARS‐Cov‐2
date: 2021-07-09
journal: Allergy
DOI: 10.1111/all.14991
sha: b9420d503ef5e329cbeb5946f54f77feb98e48de
doc_id: 779280
cord_uid: jh0zywrq

The latest outbreak of a coronavirus disease in 2019 (COVID‐19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), evolved into a worldwide pandemic with massive effects on health, quality of life, and economy. Given the short period of time since the outbreak, there are several knowledge gaps on the comparative and zoonotic aspects of this new virus. Within the One Health concept, the current EAACI position paper dwells into the current knowledge on SARS‐CoV‐2’s receptors, symptoms, transmission routes for human and animals living in close vicinity to each other, usefulness of animal models to study this disease and management options to avoid intra‐ and interspecies transmission. Similar pandemics might appear unexpectedly and more frequently in the near future due to climate change, consumption of exotic foods and drinks, globe‐trotter travel possibilities, the growing world population, the decreasing production space, declining room for wildlife and free‐ranging animals, and the changed lifestyle including living very close to animals. Therefore, both the society and the health authorities need to be aware and well prepared for similar future situations, and research needs to focus on prevention and fast development of treatment options (medications, vaccines).

In 2019, an outbreak of a new coronavirus (CoV) disease was reported in China as a cluster of pneumonia cases originating from an unknown source in the city of Wuhan. 1 responsible for less than 1000 deaths. 3, 6 Orthocoronavirinae is a subfamily of Coronaviridae (order Nidoviridae) and were divided into four different genera: alpha-, beta-, gamma-, and delta-coronaviruses. 7 

The primary receptor for SARS-CoV-2 in humans and several animal species is angiotensin-converting enzyme-2 (ACE2). [13] [14] [15] [16] ACE2 is a transmembrane glycoprotein, which physiologically functions as a peptidase, cleaving angiotensin 2 into vasodilator heptapeptide angiotensin-(1-7). The receptor-binding domain (RBD) of the viral envelope spike protein (S) binds to ACE2, independently of its catalytic enzymatic site. The S protein in SARS-CoV-2 has a polybasic furin cleavage site, which enables its cleavage into S1 and S2 subunits, which activates spike proteins and facilitates virus fusion with cellular membranes and entrance to the host cells. 13 Various cellular proteases, such as furin, transmembrane protease serine subtype 2 (TMPRSS2), cathepsin L and B, can cleave the S protein and thus facilitate viral entry into the host cells. 17 , 18 The cleavage process also provides the C-terminal sequence, which can bind to neuropilin-1 (NRP-1), and provides an additional entrance receptor for SARS-CoV-2. 19, 20 Other host proteins stabilize ACE2 structure and prevent its utilization as entry site, for example, B 0 AT1, an amino acid transporter in enterocytes. 21 ACE2 in humans is highly expressed in ciliated epithelial cells of respiratory tract, pneumocytes type II, small intestine, endothelial cells, heart, and kidney, but not on innate and adaptive immune cells. [22] [23] [24] [25] Various CoVs can utilize also other host proteins and infect cells that do not express the primary receptor. For SARS-CoV-1 such free-ranging animals, and the changed lifestyle including living very close to animals. Therefore, both the society and the health authorities need to be aware and well prepared for similar future situations, and research needs to focus on prevention and fast development of treatment options (medications, vaccines).

companion animals and pets, coronavirus, disease transmission, One Health, (reverse) zoonosis, F I G U R E 1 Timeline of the three coronaviruses causing pandemic events in the last 20 year. 3 Patients suffering from COVID-19 experience numerous different symptoms due to organ-specific expression patterns of SARS-CoV-2 receptors (Section 2.1) and immunological changes, some of them applicable for prediction of disease severity. 55 The percentage of patients remaining completely asymptomatic after real-time polymerase chain reaction (RT-PCR)-confirmed SARS-CoV-2 infection varies largely, ranging from 1.6% in a Chinese study including 72,314 tested patients to over 50% in two studies including 3711 or 76 patients, respectively. 56 The median incubation period is 5.1 days, and 97.5% of patients show symptoms within 11.5 days after infection. 57 During the early pandemic in spring 2020, fever ( Among the pediatric population, more adolescents with comorbidities develop ARDS. 72 Surprisingly, there was no increased prevalence in allergic patients (details in supplement and in compendium 73 ).

Feline coronavirus (FCoV), an alpha-coronavirus, is a common but generally harmless coronavirus, 74 that however sometimes causes the fatal disease feline infectious peritonitis (FIP). 75, 76 FCoV is extremely common in the cat population worldwide, especially in multi-cat environments, with up to 80% of cats in catteries being infected. 77 FCoV is transmitted by fecal-oral route between felids, but is not infectious for other species (including humans). FCoV usually does not cause clinical signs, and only rarely is considered responsible for transient and mild diarrhea. 78 As mentioned, sporadically, in about 5% of FCoV-infected cats in multi-cat environments, FIP occurs, 79 a study in USA testing swabs (over 5000 feline, canine, and equine samples) by RT-PCR for SARS-CoV-2 did not detect positive cats. 95 In a Chinese study, 15 out of 102 (14.7%) cat sera collected follow-

ing the outbreak in Wuhan tested positive for antibodies against the RBD, 11 cats having neutralizing antibody-titers ranging from 20 to 1080. In 2 cats monitored over 130 days, serum antibodies peaked 10 days after first sampling and declined below detection limit within 110 days. 96 In the Netherlands, 2 out of 500 evaluated cats (0.4%) had anti-RBD antibodies. 97 In a large-scale study including 817 companion animals in Northern Italy at a time of frequent human infections, no cat tested RT-PCR-positive, but 3.9% of cats had anti-RBD antibodies. 98 In France, among 20 students (2 out of 20 testing positive for SARS-CoV-2 RNA, with 11 out of 18 with symptoms of COVID-19), none of the 9 cats living in the community tested positive for RNA or antibodies. 99 In Rio de Janeiro, 39 pets (29 dogs and 10 cats) of 21 patients were tested, where 9 dogs (31%) and 4 cats (40%) from 10 (47.6%) households were infected with or seropositive for SARS-CoV-2; the study also showed that neutering and sharing of bed posed the highest risk factors for pet infection. 100

FCoV can be classified based on differences in antigenic and genomic properties in type I FCoV (more common worldwide) and 

Two coronaviruses are commonly found in dogs, CECoV (an alpha-coronaviruses) and canine respiratory coronavirus (CRCoV) (a beta-coronavirus). 74 CECoV is widespread in the dog population, primarily in kennels and shelters. Infection is usually asymptomatic, 123 

CECoV uses aminopeptidase-N as receptor. 103 CRCoV, like BCoV, binds to the cell surface via sialic acids (preferentially to α-2,3-linked sialic acids rather than α-2,6-linked sialic acids), and leukocyte anti- 

The avian infectious bronchitis virus (IBV) belongs to genus gammacoronaviruses, being a single-stranded, and positive-sense RNA virus. [133] [134] [135] This extremely contagious disease causes serious economic losses worldwide in the poultry industry affecting meat-type (broilers) and egg-laying birds (layers). 136 , 137 The respiratory and reproductive tract are affected, together with the renal system due to the broad tissue tropism of galliform and non-galliform birds for the IBV, causing morbidity up to 100%. Mortality is low but can reach 50% with some strains that cause nephritis or when opportunistic pathogens, for example, Escherichia coli complicate the disease. 133, 136, [138] [139] [140] [141] [142] The economic impact includes decreased egg production, reduced hatchability in breeders, poor external, and internal egg quality in layers as well in breeders, retarded growth, poor carcass weight, and increased condemnation rates in broilers. 133, 134, 137, 138 When affected with damage of the reproductive tract, in young pullets (layers and breeders) failure of production can occur. 133, 136, 138 IBV has an incubation period of 24 to 48 hours, and the virus spreads rapidly among chickens in a flock via aerosol and mechanical routes. IBV is shedded in feces and nasal secretions. [133] [134] [135] [136] [137] [138] Currently, avian species and poultry unlikely play a role as reservoir, host, or in transmission of either SARS-CoV-2 or MERS-CoV. 143 

The IBV receptor-binding domain (RBD) in the surface S1-spike glycoprotein is most important for the attachment to host cells. [138] [139] [140] [141] [142] 144 Variation in S1-glycoprotein partly influences tissue tropism, virulence, and virus entry. 138, 141, 142 IBV infects trachea, kidney, and the reproductive tract through interaction of the S1-glycoproteins RBD with α-2,3-linked sialic acid receptors on the cell surface. 133, 138, 141, 142 

Different serotypes and genetic types of IBV have been identified worldwide and mostly do not cross-protect. 136 Considerable milk losses may be observed in a herd affected by winter dysentery. 148, 153 Only one serotype has been identified among BCoV isolates, but some antigenic and genetic differences have been observed between isolates. 148, 153 The incubation period in young calves is estimated to be 24-48 hours, and clinical signs usually occur after five days of age, when the level of maternal virus-specific colostrum-derived antibodies decreases in the digestive tract of the calf. 148 The morbidity rate is high, varying between 50 and 100%, and the mortality rate varies according to the level of maternally or actively derived antibodies and the severity of dehydration. 148, 153, 154 BCoV shedding occurs in feces and nasal secretions. [147] [148] [149] 157 For SARS-CoV-2, under experimental conditions, cattle show low susceptibility, and there was no intraspecies transmission to incontact infection observed. 158 Therefore, there is no indication that cattle play a role in the human pandemic, and no reports of naturally infected bovines exist to date.

BCoV is an enteric/respiratory virus, using the 9-0-acetylated sialic acid as a receptor to infect cultured cells. 149 

The symptomatic treatment is directed against the dehydration and acid-base disequilibrium, which follows the diarrhea. 152 Prevention of infection is based on biosecurity, sanitary, and medical measures. 152 Clinical signs can be reduced by following sound husbandry rules. 152, 153, 157, 159 The preferred strategy is vaccination of the mother with live and inactivated vaccines to enrich the maternal colostrum with specific antibodies against BCoV. 150 There is no evidence that SARS-CoV-2 can infect or cause a disease in horses, or that they could transmit the virus to other species.

Limited published comparisons of sequences and derived structures of ACE2 in different species resulted in discrepant predictions regarding the susceptibility of horses to SARS-CoV-2 infection, ranging from high risk 45 to low risk. 46 

Most horses recover spontaneously. Those with persistent fever and anorexia are treated with anti-inflammatory drugs. More intensive treatment with intravenous fluids is needed for horses with colic or diarrhea. 171 Prevention of ECoV infection was tested using BCoV vaccine in horses to induce antibodies against ECoV, but it has not been shown to be protective. 172 There is no evidence of natural infection or disease caused by SARS-Cov-2 in pigs. Attempts to infect pigs yielded conflicting results, mostly showing that pigs are not susceptible, 174,175 but a recent study could detect virus RNA in some pigs after oronasal inoculation of 1x10 6 PFU. 176 Some of these pigs also showed mild symptoms, such as ocular or nasal discharge. One pig also developed cough and from submandibular lymph node of this pig live virus could be isolated.

Aminopeptidase N is the major receptor for porcine coronaviruses.

It has been shown that SARS-Cov-2 can use porcine ACE2 to enter HeLa cells expressing this receptor. 177 A BLAST query predicted 98% coverage and 81% identity between human and porcine ACE2. 176

Treatment of affected newborn piglets is usually ineffective. In pig- 

Many studies tried to establish a suitable animal model for the SARS-CoV-2 infection; 181 however, no ideal matching model was found. 182

Due to the entry receptor similarity, great apes and primates (rhesus macaques) seem to be most suitable, as they get infected, spread the virus, and show symptoms. 46 

The One Health movement introduced the concept that people and their animals share the environment, including infections, pollution, food, lifestyle, and increased life expectancy. In this shared scenario, not only the unidirectional (zoonotic), 3, 191 but the bidirectional transmission (reverse zoonosis) of SARS-CoV-2 virus can be envisaged. The transmission route and potential origin-host-interactions are important aspects to consider for primary and secondary prevention of infectious diseases (Figure 3 ). For the novel SARS-CoV-2, genetic analyses showed a high similarity with a coronavirus carried by bats (Table 1) .

it is likely that they are the natural host of SARS-CoV-2 too. [192] [193] [194] [195] [196] While at the onset of the SARS-CoV-2 pandemic, transmission from animals to humans was in focus, many other reports of naturally infected cats and dogs revealed that SARS-CoV-2 can be transmitted from infected humans to animals. There is also evidence of human-to-non-domestic felid transmission, as the case of a New ? ?

Himalayan palm civet cat, or raccoon dog 16, [192] [193] [194] 216 MERS-CoV Bat Dromedary camels 16, 192, 193, 217 SARS-CoV-2 bat * Pangolins*, snakes (Chinese krait and cobra snakes)*, frogs*, (sea) turtles* 16, 192, 218, 219 * under investigation.

York zoo showed, where in April 2020 it was reported that five tigers and three lions of the Wildlife Conservation Society's Bronx Zoo had developed respiratory signs. 197 In the Netherlands and Denmark, SARS-CoV-2 outbreaks have occurred in 17 mink farms in which human-to-mink, mink-to-human, and mink-to-cat/dog transmission occurred. 198-201

For SARS-CoV-2, respiratory transmission is the most important route. 202 Spreading of respiratory viruses usually happens from person to person per droplets, fomites, or aerosols. 202, 203 The effective reproduction rate for SARS-CoV-2 was found to be very high until

May 2020, with one person infecting 3 (range 2.5-3.6) other people, positioning COVID-19 as a highly contagious disease. 204 For SARS-CoV-1 and MERS-CoV, fecal-oral transmission is also important.

Since SARS-CoV-2 can be found in stool samples, this route could be relevant also for SARS-CoV-2. 203, [205] [206] [207] A study compared the structural features of ACE2 receptors in vertebrates, to estimate the risk of other species to get infected by SARS-CoV-2. 46 Susceptibility of different species is considered to be low or moderate ( Cat-to-cat transmission was demonstrated 174, 187, 208 (uninfected cats co-housed with infected cats develop antibodies 187, 208 ) , and a very high rate of intraspecies transmission was described in minks.

Several reports confirm human-to-animal transmission (reverse zoonosis). Infected animals had close contact with the RT-PCR-positive humans, suggesting that the virus was transferred in one direction (human-to-animal). Dogs, cats, wild felines (tigers and lions), and minks on fur farms were tested RT-PCR-positive, 3, 191, 199, 209 There is also concern that cats or dogs could transmit SARS-CoV-2, although there is no evidence for zoonotic transmission so far. 214 Thus, owners in some countries started to abandon their pets, however, fear of potential transmission from domestic cats is unnecessary without solid proof of risk. On the contrary, according to computational modeling, abandoning domestic cats actually might cause even more people to be infected overall. have been closed.

Fact 1: The transmission probability of SARS-CoV-2 including all its mutant versions between human-to-human is high and occurs via secretory fluids (nasal, oral, and lung). (Table 1) . It is also not completely understood which transmission ways are relevant, neither for interspecies transfer for animals, nor cross-species-wise in a zoonotic way from animals to humans (which are relevant?), or reverse-zoonotic way (do infected humans pose a differing risk to different animal species in close proximity?)

• In all species, the efficacy of an established immune response against SARS-CoV-2 (eg, neutralizing antibodies) as well as its duration are not known, due to the short duration of the pandemic (1.5 years).

• Mutations of SARS-CoV-2 take place roughly every two weeks. More than 20 genetically stable mutations might have taken place already since the outbreak, however, for many the impact on the infectibility, transferability, disease severity, and treatment are not known, both for humans and animals. Caretaker and staff must follow the hygienic protocols and the animals' health should be monitored very closely for signs of possible SARS-CoV-2 infection.

In 

The authors have nothing to disclose.

KADJ authored text about transmission, animal models, and pre- 

Humans should be careful and maintain high hygienic standards for themselves and to protect the animals and prevent further interspecies transmission • Infected owners should wear mouth-nose-protection, also during food preparation for the animal; no eating or drinking should take place in close proximity to each other, including no sharing of foods or drinks, or bed. • Infected owners should regularly wash and disinfect hands. • Quarantine/isolation should also be applied to pets in the COVID−19-affected human families; pets should not interact with other people/animals from other households • Other people should take care of the animal if holder is SARS-CoV−2-positive; if this is not feasible, keep distance from the animal as far as possible and wear mouth-nose-protection. • If animals are tested positive, they should be kept away from other animals and humans, and public places or dog parks, where it can be crowded, should be avoided. • Humans and their animals should not consume exotic animals, their meats, or products made thereof, especially if sold and kept in a clustered way under unsanitary conditions ("wet markets").

COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't

WHO coronavirus disease (COVID-19) dashboard

COVID-19: animals, veterinary and zoonotic links

COVID-19: zoonotic aspects

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Middle East respiratory syndrome coronavirus (MERS-CoV)

Emerging coronaviruses: Genome structure, replication, and pathogenesis

International Committee on Taxonomy of Viruses I. ICTV Master Species List

Multisystem inflammatory syndrome in U.S. children and adolescents

COVID-19, SARS and MERS: are they closely related?

Overview of lethal human coronaviruses

Properties of Coronavirus and SARS-CoV-2

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?

Protease inhibitors targeting coronavirus and filovirus entry

Cell entry mechanisms of SARS-CoV-2

Neuropilin-1 is a host factor for SARS-CoV-2 infection

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in various human tissues and immune cells in health and disease

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues

Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses

Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus

SARS-CoV-2 spike protein interacts with multiple innate immune receptors

CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells

Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia

No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor

Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI)

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors

Identification of sialic acidbinding function for the Middle East respiratory syndrome coronavirus spike glycoprotein

Molecular diversity of coronavirus host cell entry receptors

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3-O-sulfated heparan sulfate

Effective inhibition of SARS-CoV-2 entry by heparin and enoxaparin derivatives

Broad and differential animal angiotensin-converting enzyme 2 receptor usage by SARS-CoV-2

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection

Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals

Comparison of severe acute respiratory syndrome coronavirus 2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts

Predicting susceptibility to SARS-CoV-2 infection based on structural differences in ACE2 across species

Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates

Structural basis for multifunctional roles of mammalian aminopeptidase N

Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV

The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. iScience

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

Hospital outbreak of Middle East respiratory syndrome coronavirus

Centers for Disease, Prevention. Preliminary clinical description of severe acute respiratory syndrome

The severe acute respiratory syndrome

Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

A systematic review of asymptomatic infections with COVID-19

The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, Multicenter Study

COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features

Prior diagnoses and medications as risk factors for COVID-19 in a Los Angeles Health System. medRxiv

Race, socioeconomic deprivation, and hospitalization for COVID-19

English participants of a national biobank

Factors leading to high morbidity and mortality of covid-19 in patients with type 2 diabetes

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection

APASL COVID-19 Liver Injury Spectrum Study)

Kidney biopsy findings in patients with COVID-19

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience

A systematic review and meta-analysis of cancer patients affected by a novel coronavirus

Clinical manifestations and outcomes of critically Ill children and adolescents with COVID-19 in New York City

A compendium answering 150 questions on COVID-19 and SARS-CoV-2

Coronavirus infections (canine and feline), including feline infectious peritonitis

Feline infectious peritonitis

Feline coronavirus: Insights into viral pathogenesis based on the spike protein structure and function

Prevalence of feline coronavirus shedding in German catteries and associated risk factors

Enteropathogens identified in cats entering a Florida animal shelter with normal feces or diarrhea

Risk of feline infectious peritonitis in cats naturally infected with feline coronavirus

Effect of feline interferon-omega on the survival time and quality of life of cats with feline infectious peritonitis

Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses

Spike protein fusion peptide and feline coronavirus virulence

Replication of feline coronaviruses in peripheral blood monocytes

Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein

Activation of p38 MAPK by feline infectious peritonitis virus regulates pro-inflammatory cytokine production in primary blood-derived feline mononuclear cells

Histopathological alterations of lymphatic tissues in cats without feline infectious peritonitis after long-term exposure to FIP virus

Coronavirus infection in cats

How close is SARS-CoV-2 to canine and feline coronaviruses?

Coronaviruses in cats and other companion animals: Where does SARS-CoV-2/COVID-19 fit?

SARS-Coronavirus (CoV)-2 and cats

SARS-CoV-2 in animals

World Organisation for Animal Health. Events in animals

speci fic-infor matio nand-recom menda tions/ quest ions-and-answe rs-on-2019n ovelcoron aviru s/event s-in-anima ls

Angiotensin-converting enzyme inhibitors in veterinary medicine

The effect of telmisartan on the ventricular systolic function in dogs with experimental supraventricular tachyarrhythmia

SARS-CoV-2 (COVID-19) RealPCR Test

A serological survey of SARS-CoV-2 in cat in Wuhan

Coronavirus disease 2019 update (382): Netherlands, animal, farmed mink

Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy

Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus

Investigation of SARS-CoV-2 infection in dogs and cats of humans diagnosed with COVID-19 in Rio de Janeiro

Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus

Emergence of pathogenic coronaviruses in cats by homologous recombination between feline and canine coronaviruses

Mutational analysis of aminopeptidase N, a receptor for several group 1 coronaviruses, identifies key determinants of viral host range

Chimeric feline coronaviruses that encode type II spike protein on type I genetic background display accelerated viral growth and altered receptor usage

Type I feline coronavirus spike glycoprotein fails to recognize aminopeptidase N as a functional receptor on feline cell lines

Intriguing interplay between feline infectious peritonitis virus and its receptors during entry in primary feline monocytes

Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis

The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies

Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis

Hepatitis C virus drugs that inhibit the SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture

Cross-protection studies between feline infectious peritonitis and porcine transmissible gastroenteritis viruses

Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly

Pathogenesis of feline infectious peritonitis: nature and development of viremia

Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization

Independent evaluation of a modified live FIPV vaccine under experimental conditions

Independent evaluation of a modified live FIPV vaccine under experimental conditions (Cornell experience). Feline practice

Antibody-dependent enhancement of feline infectious peritonitis virus infection

Vaccination against naturally-occurring FIP in a single large cat shelter

Evaluation of the safety and efficacy of a modified-Live FIPV vaccine under field conditions

Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: Safety and efficacy under field conditions

Persistence and transmission of natural type I feline coronavirus infection

Patterns of feline coronavirus infection and fecal shedding from cats in multiple-cat environments

Comparison of the prevalence of enteric viruses in healthy dogs and those with acute haemorrhagic diarrhoea by electron microscopy

Molecular characterisation of the virulent canine coronavirus CB/05 strain

Canine coronavirus highly pathogenic for dogs

Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease

Isolation and sequence analysis of canine respiratory coronavirus

Prevalence of canine influenza virus A (H3N8) in dogs in Germany

Canine respiratory viruses

Canine respiratory coronavirus. Bovine coronavirus, and human coronavirus OC43: receptors and attachment factors

Efficacy of a new canine origin, modified live virus vaccine against canine coronavirus

An update on canine coronaviruses: viral evolution and pathobiology

Sialic acid is a receptor determinant for infection of cells by avian Infectious bronchitis virus

Coronaviruses in poultry and other birds

Avian infectious bronchitis virus in Africa: a review

Review of infectious bronchitis virus around the world

An overview of infectious bronchitis virus in chickens

Pathogenesis and diagnostic approaches of avian infectious bronchitis

Etiology and immunology of infectious bronchitis virus

Coronavirus avian infectious bronchitis virus

Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis

Novel receptor specificity of avian gammacoronaviruses that cause enteritis

Lack of susceptibility to SARS-CoV-2 and MERS-CoV in poultry

The sequence of the full spike S1 glycoprotein of infectious bronchitis virus circulating in Egypt reveals evidence of intragenotypic recombination

Safety and efficacy of attenuated classic and variant 2 infectious bronchitis virus candidate vaccines

Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicity

Respiratory disease associated with bovine coronavirus infection in cattle herds in Southern Italy

Infectious and Parasitic Diseases of Livestock

Bovine respiratory coronavirus

Sero-prevalence, crossspecies infection and serological determinants of prevalence of Bovine Coronavirus in Cattle, Sheep and Goats in Ghana

Bovine-like coronaviruses in domestic and wild ruminants

Bovine coronavirus uses N-acetyl-9-Oacetylneuraminic acid as a receptor determinant to initiate the infection of cultured cells

Severe outbreak of bovine coronavirus infection in dairy cattle during the warmer season

Bovine coronavirus associated syndromes

Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses

Bovine coronavirus in naturally and experimentally exposed calves; viral shedding and the potential for transmission

Passive immunity to control Bovine coronavirus diarrhea in a dairy herd in Argentina

Experimental infection of cattle with SARS-CoV-2

Structure, Function, and Evolution of Coronavirus Spike Proteins

Characterization of a coronavirus isolated from a diarrheic foal

Coronavirus and gastroenteritis in foals

Isolation of coronavirus-like agent from horses suffering from acute equine diarrhoea syndrome

Concurrent cryptosporidium and coronavirus infections in an Arabian foal with combined immunodeficiency syndrome

Isolation of an equine coronavirus from adult horses with pyrogenic and enteric disease and its antigenic and genomic characterization in comparison with the NC99 strain

Epidemic of equine coronavirus at Obihiro Racecourse, Hokkaido, Japan in 2012

Emerging outbreaks associated with equine coronavirus in adult horses

First detection of equine coronavirus (ECoV) in Europe

Experimental inoculation of equine coronavirus into Japanese draft horses

Clinical presentation, diagnostic findings, and outcome of adult horses with equine coronavirus infection at a veterinary teaching hospital: 33 cases (2012-2018)

Disease associated with equine coronavirus infection and high case fatality rate

Equine coronavirus: an emerging enteric virus of adult horses

Antibody response to equine coronavirus in horses inoculated with a bovine coronavirus vaccine

A New Bat-HKU2-like Coronavirus in Swine

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2

SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study

Susceptibility of domestic swine to experimental infection with severe acute respiratory syndrome coronavirus 2

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

Structural analysis of COVID-19 spike protein in recognizing the ACE2 receptor of different mammalian species and its susceptibility to viral infection

European Centre for Disease and Control. Monitoring of SARS-CoV-2 infection in mustelids

Animal models for COVID-19

Selection of animal models for COVID-19 research

Respiratory disease in rhesus macaques inoculated with SARS-CoV-2

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Syrian hamster as an animal model for the study on infectious diseases

Susceptibility of livestock and companion animals to COVID-19

SARS-CoV-2 infection, disease and transmission in domestic cats

Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility

SARS-CoV-2 is transmitted via contact and via the air between ferrets

Pathogenesis, transmission and response to re-exposure of SARS-1 CoV-2 in domestic cats

The risk of SARS-CoV-2 transmission to pets and other wild and domestic animals strongly mandates a one-health strategy to control the COVID-19 pandemic

SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far

The novel zoonotic COVID-19 pandemic: an expected global health concern

Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans

Animal coronaviruses and SARS-CoV-2

SARS-CoV-2/COVID-19

Revie wrepo r t/Revie w?page_refer =MapFu llEve ntRep or t&repor tid=33885

Coronavirus rips through Dutch mink farms, triggering culls

SARS-CoV-2 infection in farmed minks, the Netherlands

Clinical and pathological findings in SARS-CoV-2 disease outbreaks in farmed mink (Neovison vison)

SARS-CoV-2 in Danish Mink Farms: course of the epidemic and a descriptive analysis of the outbreaks in 2020

Transmission of SARS-CoV-2: an update of current literature

Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak

Meta-analysis on serial intervals and reproductive rates for SARS-CoV-2

The genetic sequence, origin, and diagnosis of SARS-CoV-2

Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission

First case of 2019 novel coronavirus in the United States

Transmission of SARS-CoV-2 in domestic cats

Possible Human-to-Dog Transmission of SARS-CoV-2, Italy, 2020. Emerg Infec Dis

SARS-CoV-2 B.1.1.7 variant of concern detected in a pet dog and cat after exposure to a person with COVID-19

Risk of SARS-CoV-2 transmission from humans to bats -An Australian assessment

Coronavirus in cat flea: findings and questions regarding COVID-19

Owner concerns that pets have Covid-19

Can pets transfer Corona onto their owners? SARS-CoV-2 in dogs and cats (Können Haustiere Corona auf ihre Besitzer bertragen?: SARS-CoV-2 bei Hunden und Katzen)

The fate of house cats during the COVID-19 pandemic

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

Evidence for camelto-human transmission of MERS coronavirus

Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak

Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2

Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2

One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2